Teva Pharmaceutical Industries Ltd Adr (TEVA)

Jul 17, 2026

What Teva Pharmaceutical Industries (TEVA)'s TEV‑408 Vitiligo Data and Funding Deal Means For Shareholders - Sahm

Jul 17, 2026

Jul 14, 2026

MINT,TEVA Volatility & Greeks - Finviz

Jul 14, 2026

Jul 14, 2026

Teva Pharmaceutical Industries (TEVA) Advances TEV 408, Is The Stock Still Cheap? - Sahm

Jul 14, 2026

Jul 12, 2026

ETFs Investing in Teva Pharmaceutical Industries Limited Sponsored ADR Stocks - TradingView

Jul 12, 2026

Jul 11, 2026

Teva (TEVA) Stock Looks Reasonable Even With A 48% Gap - Sahm

Jul 11, 2026

Jul 10, 2026

Teva (TEVA) Advances TEV 408 Into Phase 2b For Vitiligo After Early Progress - Sahm

Jul 10, 2026

Jul 09, 2026

Novartis vs. Teva: Which Pharmaceutical Stock Is a Better Buy in 2026? - The Motley Fool

Jul 09, 2026

Jul 09, 2026

Teva and Polpharma Biologics Announce Global Licensing Agreement for a Biosimilar Candidate to Ocrevus® (ocrelizumab) for Multiple Sclerosis - Sahm

Jul 09, 2026

Jul 08, 2026

Teva Reports Early Skin Repigmentation Data, Sets Stage For Next Trial - Sahm

Jul 08, 2026

Jul 07, 2026

TEVA Stock Price | Analyst Target 42.38 & Strong Buy Consensus - eToro

Jul 07, 2026

Jul 06, 2026

Teva stock leans on its generic drug base. - Ad-hoc-news.de

Jul 06, 2026

Jul 05, 2026

883035 Forecast — Price Target — Prediction for 2027 - TradingView

Jul 05, 2026

Jul 03, 2026

TEVATeva- Pharmaceutical Industries Ltd ADR Latest SEC Filings - Finviz

Jul 03, 2026

Jul 02, 2026

How Teva’s Ecopipam NDA for Pediatric Tourette Syndrome (TEVA) Has Changed Its Investment Story - Sahm

Jul 02, 2026

Jul 02, 2026

TEVA Stock Price, Quote & Chart - ChartMill

Jul 02, 2026

Jun 28, 2026

Enterprise value to revenue forward of Teva Pharmaceutical Industries Limited Sponsored ADR – BX:TEV - TradingView

Jun 28, 2026

Jun 28, 2026

Price to earnings forward of Teva Pharmaceutical Industries Limited Sponsored ADR – BX:TEV - TradingView

Jun 28, 2026

Jun 26, 2026

TEV Forecast — Price Target — Prediction for 2027 - TradingView

Jun 26, 2026

Jun 26, 2026

TEVA Forecast — Price Target — Prediction for 2027 - TradingView

Jun 26, 2026

Jun 26, 2026

TEVA/N Forecast — Price Target — Prediction for 2027 - TradingView

Jun 26, 2026

Jun 26, 2026

Enterprise value to revenue forward of Teva Pharmaceutical Industries Limited Sponsored ADR – FWB:TEV - TradingView

Jun 26, 2026

Jun 26, 2026

Price to earnings forward of Teva Pharmaceutical Industries Limited Sponsored ADR – FWB:TEV - TradingView

Jun 26, 2026

Jun 25, 2026

Enterprise value to EBITDA forward of Teva Pharmaceutical Industries Limited Sponsored ADR – FWB:TEV - TradingView

Jun 25, 2026

Jun 25, 2026

Teva Pharmaceutical Industries Ltd Unsponsored Brazilian Depositary Receipt Repr 0.5 ADR - TradingView

Jun 25, 2026

Jun 24, 2026

Teva Pharmaceutical Industries Limited Sponsored ADR - TradingView

Jun 24, 2026

Jun 23, 2026

TEVA News | TEVA PHARMACEUTICAL-SP ADR (NYSE:TEVA) - ChartMill

Jun 23, 2026

Jun 23, 2026

Teva's Shift Beyond Generics Puts Focus on Branded Drug Growth - TradingView

Jun 23, 2026

Jun 22, 2026

How Teva’s Ecopipam Tourette NDA and AUSTEDO Data Will Impact Teva Pharmaceutical Industries (TEVA) Investors - Sahm

Jun 22, 2026

Jun 21, 2026

Teva Pharmaceutical Industries (TEVA) Stock Could Be 23.7% Undervalued After Recent Pullback - Sahm

Jun 21, 2026

Jun 19, 2026

Teva Seeks FDA Nod for Ecopipam in Pediatric Tourette Syndrome - Yahoo Finance

Jun 19, 2026

Jun 18, 2026

Teva submits new drug application for pediatric Tourette treatment By Investing.com - Investing.com Canada

Jun 18, 2026

Jun 17, 2026

FOCUS-US progesterone supplies tighten as menopause treatment demand grows - Sahm

Jun 17, 2026

Jun 12, 2026

Teva Extends Neuroscience Focus With Emalex Deal And Valuation Upside Potential - Sahm

Jun 12, 2026

Jun 10, 2026

Teva Closes Acquisition of Emalex Biosciences, Strengthening Late-Stage Neuroscience Pipeline and Advancing Pivot to Growth Strategy - Sahm

Jun 10, 2026

Jun 09, 2026

symbol__ Stock Quote Price and Forecast - CNN

Jun 09, 2026

Jun 05, 2026

ALVO Stock Gains 19% on FDA Resubmission of Biosimilar BLAs - TradingView

Jun 05, 2026

Jun 04, 2026

How Investors May Respond To Teva (TEVA) Pivoting From Generics Toward Higher-Margin Branded Therapies - Sahm

Jun 04, 2026

Jun 01, 2026

Teva stock hits 52-week high at $32.02 By Investing.com - Investing.com Nigeria

Jun 01, 2026

May 31, 2026

Assessing Teva (NYSE:TEVA) Valuation After New IMPACT-TD Registry Findings On Tardive Dyskinesia - Sahm

May 31, 2026

May 30, 2026

TEVA PHARMACEUTICAL-SP ADR (NYSE:TEVA) Flags Technical Breakout Setup with Top Ratings - ChartMill

May 30, 2026

May 29, 2026

Teva- Pharmaceutical Industries Ltd.ADR (TEVA) News, Articles, Events & Latest Updates - Stocktwits

May 29, 2026

May 27, 2026

Updating Moat and Valuation for Teva to Reflect Improved Outlook - Morningstar

May 27, 2026

May 27, 2026

Teva: Upgrading Moat and Raising Valuation on Portfolio Improvements and Deep Pipeline - Morningstar

May 27, 2026

May 25, 2026

Here's How Much $100 Invested In Teva Pharmaceutical Indus 5 Years Ago Would Be Worth Today - Sahm

May 25, 2026

May 24, 2026

A Look At Teva (NYSE:TEVA) Valuation After EMA Accepts Filing For Monthly Schizophrenia Injection - Sahm

May 24, 2026

May 23, 2026

Teva Pharmaceutical Industries Limited Sponsored ADR Trade Ideas — LSX:883035 - TradingView

May 23, 2026

May 23, 2026

Will Teva’s New TD Data on Young Adults Shift Its Neuroscience-Focused Investment Narrative (TEVA)? - Sahm

May 23, 2026

May 20, 2026

Teva Pharmaceutical’s SWOT analysis: stock navigates growth reset - Investing.com

May 20, 2026

May 20, 2026

Teva Shares Rise Following Launch of First Generic GLP-1 Weight Loss Drug - MSN

May 20, 2026